Please login to the form below

Not currently logged in
Email:
Password:

NHS news in brief

Our weekly round-up of NHS and healthcare stories

New inquiry into NHS IT upgrade
The National Audit Office (NAO) is to launch another inquiry into the controversial ?6.8bn NHS IT upgrade project. The programme, run by a governmental agency called Connecting for Health, aims to link 30,000 GPs with 300 hospitals in England. The NAO issued a report in June, criticising delays in the project. It said the exact remit and timescale of the new investigation had not been decided yet. ìWhen we published the report, we said we may revisit it and that is what we are doing,î said an NAO spokesman.

Pyschiatrists call for Alzheimer's drug rethink
In a study, psychiatrists have called for a re-examination of the way resources are allocated on the NHS for dementia care, and in particular the use of cholinesterase inhibitors. In 2001, the National Institute for Health and Clinical Excellence (NICE) recommended that licensed cholinesterase inhibitors donepezil, rivastigmine and galantamine be made available on the NHS for the treatment of mild-to-moderate Alzheimer's disease. However, the research has revealed ìquite consistently that these medicines have modest beneficial effects compared with placebo,î according to the report's lead author, Anthony Pelosi, consultant psychiatrist at Hairmyres Hospital in Scotland.

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Infographics